The prescribing provider understands the full medical picture and may have context about the rate of weight loss or other factors that are relevant
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, improve insulin secretion, and increase energy expenditure
Many plans, including Medicare and Medicaid, are more likely to pay for semaglutide when its prescribed for diabetes than for weight loss
Zepbound (tirzepatide) Approved uses: People with overweight or obesity and moderate-to-severe obstructive sleep apnea Drug type: Once-weekly injection Doses: 2.5 mg (initial dose), 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg Cost: With commercial insurance that includes Zepbound coverage, the cost of a three-month prescription is as low as $25
Gives an Impressive Muscle Pump: Enhances circulation, delivers the desired muscle pump, and boosts confidence and motivation to push your progress further